Silo Pharma, Inc.
SILONasdaqCIK 1514183HealthcareFiscal year ends Dec 31
Reports and events: 182 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1420:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-109457 |
| 2026-10-0220:37 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-106435 |
| 2026-08-1921:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-091783 |
| 2026-08-1720:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-090748 |
| 2026-08-1320:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-089085 |
| 2026-07-1322:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-077296 |
| 2026-06-3011:06 ET | DEF 14A | Proxy statementPeriod 2026-08-14 | 0001213900-26-073367 |
| 2026-06-1821:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-070212 |
| 2026-06-0321:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-064804 |
| 2026-06-0113:02 ET | 8-K | 8.01 Other events | 0001213900-26-063185 |
| 2026-05-1423:54 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-056079 |
| 2026-04-0220:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-039352 |
| 2026-03-2720:40 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-035576 |
| 2026-02-2322:00 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019384 |
| 2025-12-2914:04 ET | 8-K | 3.01 Delisting notice | 0001213900-25-125838 |
| 2025-11-1321:18 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-110006 |
| 2025-10-2922:32 ET | S-1 | Registration statement | 0001213900-25-103188 |
| 2025-10-2420:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-102222 |
| 2025-10-0120:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-094711 |
| 2025-09-0521:05 ET | DEF 14A | Proxy statementPeriod 2025-10-24 | 0001213900-25-085119 |
| 2025-08-1320:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-075693 |
| 2025-08-0520:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-072062 |
| 2025-07-2920:32 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-068740 |
| 2025-07-1020:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-062805 |
| 2025-07-0320:45 ET | 8-K | 3.01 Delisting notice | 0001213900-25-061531 |
| 2025-05-1620:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-044913 |
| 2025-05-0920:32 ET | S-1/A | Registration statement, amended | 0001213900-25-041563 |
| 2025-05-0920:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-041519 |
| 2025-04-2911:39 ET | S-1/A | Registration statement, amended | 0001213900-25-036374 |
| 2025-04-2521:10 ET | S-1 | Registration statement | 0001213900-25-035652 |
| 2025-03-2820:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001013762-25-004139 |
| 2025-03-1011:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-021916 |
| 2025-03-0712:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-021345 |
| 2025-01-0216:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-000191 |
| 2024-12-2022:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-111256 |
| 2024-11-1221:42 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-096841 |
| 2024-11-0821:03 ET | 8-K | 8.01 Other events | 0001213900-24-095886 |
| 2024-09-1820:15 ET | DEF 14A | Proxy statementPeriod 2024-11-12 | 0001213900-24-079883 |
| 2024-09-1010:46 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-077111 |
| 2024-08-2121:20 ET | S-1 | Registration statement | 0001213900-24-071525 |
| 2024-08-1320:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068296 |
| 2024-07-2520:30 ET | S-1/A | Registration statement, amended | 0001013762-24-001151 |
| 2024-07-2221:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-24-000518 |
| 2024-07-1720:45 ET | S-1 | Registration statement | 0001213900-24-062184 |
| 2024-07-0820:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-059821 |
| 2024-06-2720:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-056678 |
| 2024-06-0620:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-050405 |
| 2024-06-0420:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-049658 |
| 2024-05-1320:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-042299 |
| 2024-04-0520:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-030805 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.